Vickro Biopharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 8 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.69 Cr
as on 24-10-2024
- Revenue 17.41%
(FY 2023)
- Profit 8.89%
(FY 2023)
- Ebitda 42.69%
(FY 2023)
- Net Worth 36.91%
(FY 2023)
- Total Assets 77.54%
(FY 2023)
About Vickro Biopharma
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.69 Cr.
Kishore Turlapati and Indirapriyadarsini Kankanampati serve as directors at the Company.
- CIN/LLPIN
U24304TG2016PTC113121
- Company No.
113121
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vickro Biopharma Private Limited offer?
Vickro Biopharma Private Limited offers a wide range of products and services, including Textile, Dyeing & Finishing Chemical, Textile Enzymes.
Who are the key members and board of directors at Vickro Biopharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishore Turlapati  | Director | 25-Nov-2016 | Current |
| Indirapriyadarsini Kankanampati | Director | 25-Nov-2016 | Current |
Financial Performance of Vickro Biopharma.
Vickro Biopharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.41% increase. The company also saw a slight improvement in profitability, with a 8.89% increase in profit. The company's net worth Soared by an impressive increase of 36.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vickro Biopharma?
In 2023, Vickro Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cognnate Biotech Private LimitedActive 8 years 3 monthsKishore Turlapati and Indirapriyadarsini Kankanampati are mutual person
- Kladis Labs India Private LimitedActive 2 years 18 days
Kishore Turlapati and Indirapriyadarsini Kankanampati are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 16 Aug 2024 | ₹1.30 Cr | Open |
Axis Bank Limited Creation Date: 21 Apr 2022 | ₹3.94 M | Open |
How Many Employees Work at Vickro Biopharma?
Vickro Biopharma has a workforce of 25 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vickro Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vickro Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
